Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02005523
Other study ID # 07.1.1.H2
Secondary ID
Status Withdrawn
Phase Phase 2
First received December 3, 2013
Last updated February 4, 2015

Study information

Verified date February 2015
Source Revalesio Corporation
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The purpose of this study is to see if use of RNS60 during hip labral repair surgery decreases pain and improves functional capacity post-operation.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date
Est. primary completion date October 2014
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
RNS60

Saline


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Revalesio Corporation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of post-operative pain Comparison of scores from validated pain scales from post-surgery to one week. 1 week No
See also
  Status Clinical Trial Phase
Completed NCT03407612 - Outcomes of CPM Usage Following Arthroscopic Acetabular Labral Repair N/A